Peter A. Ward

66.4k total citations · 15 hit papers
690 papers, 53.1k citations indexed

About

Peter A. Ward is a scholar working on Immunology, Molecular Biology and Epidemiology. According to data from OpenAlex, Peter A. Ward has authored 690 papers receiving a total of 53.1k indexed citations (citations by other indexed papers that have themselves been cited), including 392 papers in Immunology, 191 papers in Molecular Biology and 93 papers in Epidemiology. Recurrent topics in Peter A. Ward's work include Immune Response and Inflammation (159 papers), Complement system in diseases (118 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (107 papers). Peter A. Ward is often cited by papers focused on Immune Response and Inflammation (159 papers), Complement system in diseases (118 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (107 papers). Peter A. Ward collaborates with scholars based in United States, Germany and Switzerland. Peter A. Ward's co-authors include Ren-Feng Guo, Daniel Rittirsch, J. Vidya Sarma, Markus Huber‐Lang, Michael A. Flierl, Niels C. Riedemann, Gerd O. Till, Joseph C. Fantone, Matthew J. Delano and Firas S. Zetoune and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Peter A. Ward

679 papers receiving 50.0k citations

Hit Papers

Immunodesign of experimental sepsi... 1982 2026 1996 2011 2008 1982 2008 1994 2005 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter A. Ward United States 121 23.1k 13.8k 8.3k 7.0k 4.8k 690 53.1k
Peter M. Henson United States 118 28.1k 1.2× 16.9k 1.2× 4.2k 0.5× 6.6k 0.9× 4.0k 0.8× 375 51.4k
Steven L. Kunkel United States 113 21.6k 0.9× 9.7k 0.7× 6.3k 0.8× 7.0k 1.0× 4.7k 1.0× 528 48.1k
Paul Kubes Canada 113 26.2k 1.1× 12.7k 0.9× 6.9k 0.8× 4.6k 0.7× 4.8k 1.0× 423 52.5k
Göran K. Hansson Sweden 101 28.1k 1.2× 14.0k 1.0× 11.5k 1.4× 3.5k 0.5× 9.5k 2.0× 455 53.2k
Siamon Gordon United Kingdom 133 41.2k 1.8× 22.0k 1.6× 10.6k 1.3× 4.0k 0.6× 4.9k 1.0× 455 78.1k
Anthony Cerami United States 135 20.7k 0.9× 18.8k 1.4× 10.8k 1.3× 4.3k 0.6× 4.7k 1.0× 514 76.7k
Robert M. Strieter United States 133 23.9k 1.0× 12.7k 0.9× 6.5k 0.8× 10.8k 1.5× 6.2k 1.3× 509 56.9k
Michael A. Gimbrone United States 103 12.9k 0.6× 16.2k 1.2× 3.3k 0.4× 4.1k 0.6× 6.4k 1.3× 185 42.7k
Nico van Rooijen Netherlands 146 38.1k 1.6× 21.4k 1.5× 13.1k 1.6× 5.3k 0.8× 8.1k 1.7× 838 80.5k
Bruce Beutler United States 112 38.1k 1.6× 17.2k 1.2× 10.8k 1.3× 4.0k 0.6× 3.1k 0.6× 406 64.5k

Countries citing papers authored by Peter A. Ward

Since Specialization
Citations

This map shows the geographic impact of Peter A. Ward's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter A. Ward with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter A. Ward more than expected).

Fields of papers citing papers by Peter A. Ward

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter A. Ward. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter A. Ward. The network helps show where Peter A. Ward may publish in the future.

Co-authorship network of co-authors of Peter A. Ward

This figure shows the co-authorship network connecting the top 25 collaborators of Peter A. Ward. A scholar is included among the top collaborators of Peter A. Ward based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter A. Ward. Peter A. Ward is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ward, Peter A., et al.. (2024). Innovative outpatient treatment for veterans and service members and their family members. Frontiers in Psychiatry. 15. 1377433–1377433. 1 indexed citations
2.
Zhang, Yong, Xiru Li, Jamison Grailer, et al.. (2016). Melatonin alleviates acute lung injury through inhibiting the NLRP3 inflammasome. Journal of Pineal Research. 60(4). 405–414. 249 indexed citations
3.
Sladojević, Nikola, Svetlana M. Stamatovic, Richard F. Keep, et al.. (2014). Inhibition of junctional adhesion molecule-A/LFA interaction attenuates leukocyte trafficking and inflammation in brain ischemia/reperfusion injury. Neurobiology of Disease. 67. 57–70. 70 indexed citations
4.
Flierl, Michael A., Daniel Rittirsch, Brian A. Nadeau, et al.. (2009). Upregulation of Phagocyte-Derived Catecholamines Augments the Acute Inflammatory Response. PLoS ONE. 4(2). e4414–e4414. 123 indexed citations
5.
Patel, Samir N., Joanne Berghout, Fiona Lovegrove, et al.. (2008). C5 deficiency and C5a or C5aR blockade protects against cerebral malaria. The Journal of Experimental Medicine. 205(5). 1133–1143. 86 indexed citations
6.
Flierl, Michael A., Daniel Rittirsch, Markus Huber‐Lang, J. Vidya Sarma, & Peter A. Ward. (2008). Molecular Events in the Cardiomyopathy of Sepsis. Molecular Medicine. 14(5-6). 327–336. 99 indexed citations
7.
Anaya‐Prado, Roberto, Luis H. Toledo‐Pereyra, Alex B. Lentsch, & Peter A. Ward. (2002). Ischemia/Reperfusion Injury. Journal of Surgical Research. 105(2). 248–258. 261 indexed citations
8.
Martínez-Mier, Gustavo, Luis H. Toledo‐Pereyra, Stuart Bussell, et al.. (2000). NITRIC OXIDE DIMINISHES APOPTOSIS AND p53 GENE EXPRESSION AFTER RENAL ISCHEMIA AND REPERFUSION INJURY1. Transplantation. 70(10). 1431–1437. 27 indexed citations
9.
Hébert, C A & Peter A. Ward. (1999). Chemokines in disease : biology and clinical research. Humana Press eBooks. 10 indexed citations
10.
Czermak, Boris J., Vidya Sarma, Nicolas M. Bless, et al.. (1999). In vitro and in vivo dependency of chemokine generation on C5a and TNF-alpha. 162(4). 1 indexed citations
11.
Ward, Peter A. & Gary W. Hunninghake. (1998). Lung Inflammation and Fibrosis. American Journal of Respiratory and Critical Care Medicine. 157(4). S123–S129. 185 indexed citations
12.
Ding, Ziqiang, Hiroto Kawashima, Yasuo Suzuki, et al.. (1997). A sulfatide receptor distinct from L‐selectin is involved in lymphocyte activation. FEBS Letters. 418(3). 310–314. 14 indexed citations
13.
Ward, Peter A.. (1994). Oxygen radicals, cytokines, adhesion molecules, and lung injury.. Environmental Health Perspectives. 102(suppl 10). 13–16. 17 indexed citations
14.
Till, Gerd O., H. P. Friedl, & Peter A. Ward. (1991). Lung injury and complement activation: Role of neutrophils and xanthine oxidase. Free Radical Biology and Medicine. 10(6). 379–386. 37 indexed citations
15.
Ward, Peter A.. (1983). Immunology of inflammation. Elsevier eBooks. 27 indexed citations
16.
Johnson, K J, William E. Chapman, & Peter A. Ward. (1979). Immunopathology of the lung: a review.. PubMed Central. 95(3). 795–844. 30 indexed citations
17.
O’Flaherty, Joseph T., et al.. (1978). Desensitization of the neutrophil aggregation response to chemotactic factors.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 93(3). 693–706. 12 indexed citations
18.
Beebe, D.P., S. Goralnick, Claude Gérard, Juris Ozols, & Peter A. Ward. (1978). The C5 Chemotactic Fragment Isolated from Activated Human Serum. The Journal of Immunology. 120(5). 1764–1764. 4 indexed citations
19.
Ward, Peter A., K J Johnson, & D. L. Kreutzer. (1977). Regulatory dysfunction in leukotaxis.. PubMed Central. 88(3). 701–10. 15 indexed citations
20.
Ward, Peter A. & Elmer L. Becker. (1968). THE DEACTIVATION OF RABBIT NEUTROPHILS BY CHEMOTACTIC FACTOR AND THE NATURE OF THE ACTIVATABLE ESTERASE. The Journal of Experimental Medicine. 127(4). 693–709. 207 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026